Applied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal Regulation
2023年4月8日 - 1:00AM
ビジネスワイヤ(英語)
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the "Company"), a
leader in PCR-based DNA technologies, announced that its CertainT®
supply chain traceability platform is featured in an article on the
home page of the New York Times website today. The article, titled
"How A.I. and DNA Are Unlocking the Mysteries of Global Supply
Chains," centers on the mounting need for the textile and other
industries to employ tracing technologies to ensure compliance with
the Uyghur Forced Labor Prevention Act (UFLPA).
Excerpt:
Some companies — like the one that sprays the
DNA mist onto cotton, Applied DNA Sciences — are using scientific
processes to tag or test a physical attribute of the good itself,
to figure out where it has traveled on its path from factories to
consumer.
Applied DNA has used its synthetic DNA tags,
each just a billionth of the size of a grain of sugar, to track
microcircuits produced for the Department of Defense, trace
cannabis supply chains to ensure the product’s purity and even to
mist robbers in Sweden who attempted to steal cash from A.T.M.s,
leading to multiple arrests.
MeiLin Wan, the vice president for textiles
at Applied DNA, said the new regulations were creating a “tipping
point for real transparency.”
In addition to the DNA mist it applies as a
marker, Applied DNA can figure out where cotton comes from by
sequencing the DNA of the cotton itself, or analyzing its isotopes,
which are variations in the carbon, oxygen and hydrogen atoms in
the cotton. Differences in rainfall, latitude, temperature and soil
conditions mean these atoms vary slightly across regions of the
world, allowing researchers to map where the cotton in a pair of
socks or bath towel has come from.
(Source: Ana Swanson, NY Times)
CertainT is a multi-layered forensic authentication system that
employs an integrated "tag-test-track" approach to maximize supply
chain security and minimize counterfeiting, including verifying
cotton's geographic region of origin.
Passed into Federal law in December 2021 and in effect since
June 2022, the UFLPA establishes a rebuttable presumption that the
importation of any goods, wares, articles, and merchandise mined,
produced, or manufactured wholly or in part in the Xinjiang Uyghur
Autonomous Region of the People's Republic of China (XUAR), or
produced by certain entities, is prohibited and the goods are not
entitled to entry to the United States.
The Department of Homeland Security's Implementation Strategy
under the UFLPA identified DNA traceability and isotopic testing -
both central components of the CertainT platform - as evidence that
importers may present to potentially prove that items do not
originate in XUAR or may have benefitted from forced labor.
About CertainT®
CertainT is a multi-layered forensic authentication system that
includes DNA tagging, DNA genotyping, and isotope testing, designed
to maximize supply chain security and minimize counterfeiting. The
CertainT platform allows for DNA-based molecular tagging of inputs
and final products, such as cotton fiber and finished cotton
products, which can be tested and tracked through global supply
chains. The CertainT platform can be used across the entire textile
industry, including cotton, viscose, polyester, leather, and down
and feather. It is well positioned to assist worldwide supply
chains in navigating the Uyghur Forced Labor Prevention Act
(UFLPA), which has been in full force since June 21, 2022, and
other due diligence regulations in other countries. Learn more
here: https://adnas.com/cotton-supply-chain-protection/
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing
technologies to produce and detect deoxyribonucleic acid ("DNA").
Using PCR to enable both the production and detection of DNA, we
operate in three primary business markets: (i) the manufacture of
DNA for use in nucleic acid-based therapeutics; (ii) the detection
of DNA in molecular diagnostics testing services; and (iii) the
manufacture and detection of DNA for industrial supply chain
security services.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
The Company's common stock is listed on NASDAQ under the ticker
symbol 'APDN.' Its publicly traded warrants are listed on OTC under
the ticker symbol 'APPDW.'
Forward-Looking Statements
The statements made by Applied DNA in this press release and
associated materials may be "forward-looking" in nature within the
meaning of Section 27A of the Securities Act of 1933, Section 21E
of the Securities Exchange Act of 1934 and the Private Securities
Litigation Reform Act of 1995. Forward-looking statements describe
Applied DNA's future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance, our unknown ability to
penetrate key markets, our ability to successfully enter into
commercial contracts for the implementation of our CertainT®
platform, the uncertainties inherent in research and development,
our unknown ability to maintain contractual relationships necessary
for isotopic testing, and various other factors detailed from time
to time in Applied DNA's SEC reports and filings, including our
Annual Report on Form 10-K filed on December 14, 2022, as amended,
its Form 10-Q filed on February 9, 2023, and other reports it files
with the SEC, which are available at www.sec.gov. Applied DNA
undertakes no obligation to update publicly any forward-looking
statements to reflect new information, events, or circumstances
after the date hereof or to reflect the occurrence of unanticipated
events, unless otherwise required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230407005125/en/
Corporate Contacts: Investor Relations Contact:
Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com Program
Contact: MeiLin Wan, 631-240-8849, meilin.wan@adnas.com
Web: www.adnas.com Twitter: @APDN
Applied DNA Sciences (NASDAQ:APDN)
過去 株価チャート
から 5 2024 まで 6 2024
Applied DNA Sciences (NASDAQ:APDN)
過去 株価チャート
から 6 2023 まで 6 2024